Page 962 - Williams Hematology ( PDFDrive )

936 Part VII: Neutrophils, Eosinophils, Basophils, and Mast Cells Chapter 60: Structure and Composition of Neutrophils, Eosinophils, and Basophils 937

68. Ohno I, Ohtani H, Nitta Y, et al: Eosinophils as a source of matrix metalloproteinase-9 103. Wood HG, Katz J, Landau BR: Estimation of pathways of carbohydrate metabolism.
in asthmatic airway inflammation. Am J Respir Cell Mol Biol 16:212, 1997. Biochem Z 338:809, 1963.
69. Gauthier MC, Racine C, Ferland C, et al: Expression of membrane type-4 matrix metal- 104. Scott RB: Glycogen in human peripheral blood leukocytes. I. Characteristics of the syn-
loproteinase (metalloproteinase-17) by human eosinophils. Int J Biochem Cell Biol thesis and turnover of glycogen in vitro. J Clin Invest 47:344, 1968.
35:1667, 2003. 105. Borregaard N, Juhl H: Activation of the glycogenolytic cascade in human polymorpho-
70. Wiehler S, Cuvelier SL, Chakrabarti S, Patel KD: p38 MAP kinase regulates rapid nuclear leucocytes by different phagocytic stimuli. Eur J Clin Invest 11:257, 1981.
matrix metalloproteinase-9 release from eosinophils. Biochem Biophys Res Commun 106. Wachstein M: The distribution of histochemically demonstrable glycogen in human
315:463, 2004. blood and bone marrow cells. Blood 4:54, 1949.
71. Lacy P, Moqbel R: Eosinophil cytokines. Chem Immunol 76:134, 2000. 107. Cassatella MA: Neutrophil-derived proteins: Selling cytokines by the pound. Adv
72. Moqbel R, Lacy P: Eosinophil cytokines, in Inflammatory Mechanisms in Asthma, Immunol 73:369, 1999.
edited by Busse WW, Holgate ST, pp 227–246. Marcel Dekker, New York, 1998. 108. Scapini P, Lapinet-Vera JA, Gasperini S, et al: The neutrophil as a cellular source of
73. Georas SN, McIntyre BW, Ebisawa M, et al: Expression of a functional laminin receptor chemokines. Immunol Rev 177:195, 2000.
(alpha 6 beta 1, very late activation antigen-6) on human eosinophils. Blood 82:2872, 1993. 109. Boneberg EM, Hartung T: Molecular aspects of anti-inflammatory action of G-CSF.
74. Grayson MH, Van der Vieren M, Sterbinsky SA, et al: alphadbeta2 integrin is expressed Inflamm Res 51:119, 2002.
on human eosinophils and functions as an alternative ligand for vascular cell adhesion 110. Cloutier A, McDonald PP: Transcription factor activation in human neutrophils. Chem
molecule 1 (VCAM-1). J Exp Med 188:2187, 1998. Immunol Allergy 83:1, 2003.
75. Tachimoto H, Bochner BS: The surface phenotype of human eosinophils. Chem Immu- 111. Cheng SS, Kunkel SL: The evolving role of the neutrophil in chemokine networks.
nol 76:45, 2000. Chem Immunol Allergy 83:81, 2003.
76. Bochner BS, Busse WW: Allergy and asthma. J Allergy Clin Immunol 115:953, 2005. 112. Gonzalez AL, El Bjeirami W, West JL, et al: Transendothelial migration enhances
77. Phillips RM, Stubbs VE, Henson MR, et al: Variations in eosinophil chemokine integrin-dependent human neutrophil chemokinesis. J Leukoc Biol 81(3):686–95,
responses: An investigation of CCR1 and CCR3 function, expression in atopy, and 2007.
identification of a functional CCR1 promoter. J Immunol 170:6190, 2003. 113. Girard D: Phenotypic and functional change of neutrophils activated by cytokines
78. Elsner J, Dulkys Y, Gupta S, et al: Differential pattern of CCR1 internalization in human utilizing the common cytokine receptor gamma chain. Chem Immunol Allergy 83:64,
eosinophils: Prolonged internalization by CCL5 in contrast to CCL3. Allergy 60:1386, 2003.
2005. 114. Tsukahara Y, Lian Z, Zhang X, et al: Gene expression in human neutrophils during
79. Ponath PD, Qin S, Post TW, et al: Molecular cloning and characterization of a human activation and priming by bacterial lipopolysaccharide. J Cell Biochem 89:848, 2003.
eotaxin receptor expressed selectively on eosinophils. J Exp Med 183:2437, 1996. 115. Malcolm KC, Arndt PG, Manos EJ, et al: Microarray analysis of lipopolysaccha-
80. Lee JH, Chang HS, Kim JH, et al: Genetic effect of CCR3 and IL5RA gene polymor- ride-treated human neutrophils. Am J Physiol Lung Cell Mol Physiol 284:L663, 2003.
phisms on eosinophilia in asthmatic patients. J Allergy Clin Immunol 120:1110, 2007. 116. Theilgaard-Monch K, Knudsen S, Follin P, Borregaard N: The transcriptional activation
81. Takatsu K, Kouro T, Nagai Y: Interleukin 5 in the link between the innate and acquired program of human neutrophils in skin lesions supports their important role in wound
immune response. Adv Immunol 101:191, 2009. healing. J Immunol 172:7684, 2004.
82. DiScipio RG, Schraufstatter IU: The role of the complement anaphylatoxins in the 117. Kobayashi SD, Voyich JM, Braughton KR, et al: Gene expression profiling provides
recruitment of eosinophils. Int Immunopharmacol 7:1909, 2007. insight into the pathophysiology of chronic granulomatous disease. J Immunol 172:636,
83. Sullivan BM, Locksley RM: Basophils: A nonredundant contributor to host immunity. 2004.
Immunity 30:12, 2009. 118. Kobayashi SD, Voyich JM, Braughton KR, DeLeo FR: Down-regulation of proinflam-
84. Gurish MF, Boyce JA: Mast cells: Ontogeny, homing, and recruitment of a unique matory capacity during apoptosis in human polymorphonuclear leukocytes. J Immunol
innate effector cell. J Allergy Clin Immunol 117:1285, 2006. 170:3357, 2003.
85. Arinobu Y, Iwasaki H, Gurish MF, et al: Developmental checkpoints of the basophil/ 119. Scott RB: Glycogen in human peripheral blood leukocytes. I. Characteristics of the syn-
mast cell lineages in adult murine hematopoiesis. Proc Natl Acad Sci U S A 102:18105, thesis and turnover of glycogen in vitro. J Clin Invest 47:344, 1968.
2005. 120. Scott RB, Still WJ: Glycogen in human peripheral blood leukocytes. II. The macromo-
86. Arinobu Y, Iwasaki H, Akashi K: Origin of basophils and mast cells. Allergol Int 58:21, lecular state of leukocyte glycogen. J Clin Invest 47:353, 1968.
2009. 121. Esman V: The glycogen content of WBC from diabetic and nondiabetic subjects. Scand
87. Falcone FH, Haas H, Gibbs BF: The human basophil: A new appreciation of its role in J Clin Lab Invest 13:134, 1961.
immune responses. Blood 96:4028, 2000. 122. Rauch HC, Loomis ME, Johnson ME, et al: In vitro suppression of polymorphonuclear
88. Gessner A, Mohrs K, Mohrs M: Mast cells, basophils, and eosinophils acquire constitu- leukocyte and lymphocyte glycolysis by cortisol. Endocrinology 68:375, 1961.
tive IL-4 and IL-13 transcripts during lineage differentiation that are sufficient for rapid 123. Martin SP, McKinney GR, Green R, et al: The influence of glucose, fructose, and insulin
cytokine production. J Immunol 174:1063, 2005. on the metabolism of leukocytes of healthy and diabetic subjects. J Clin Invest 32:1171,
89. Siracusa MC, Wojno ED, Artis D: Functional heterogeneity in the basophil cell lineage 1953.
1. Adv Immunol 115:141, 2012. 124. Gottfried EL: Lipids of human leukocytes: Relation to cell type. J Lipid Res 8:321, 1967.
90. Wedemeyer J, Tsai M, Galli SJ: Roles of mast cells and basophils in innate and acquired 125. Gottfried EL: Lipid patterns of leukocytes in health and disease. Semin Hematol 9:241,
immunity. Curr Opin Immunol 12:624, 2000. 1972.
91. Marone G, Galli SJ, Kitamura Y: Probing the roles of mast cells and basophils in natural 126. Nishizuka Y: Studies and perspectives of protein kinase C. Science 233:305, 1986.
and acquired immunity, physiology and disease. Trends Immunol 23:425, 2002. 127. Berridge MJ, Irvine RF: Inositol trisphosphate, a novel second messenger in cellular
92. Dvorak AM: Histamine content and secretion in basophils and mast cells. Prog His- signal transduction. Nature 312:315, 1984.
tochem Cytochem 33:III, 1998. 128. Symington FW, Murray WA, Bearman SI, et al: Intracellular localization of lactosylcer-
93. Beck WS, Valentine WN: The aerobic carbohydrate metabolism of leukocytes in health amide, the major human neutrophil glycosphingolipid. J Biol Chem 262:11356, 1987.
and leukemia. I. Glycolysis and respiration. Cancer Res 12:818, 1952. 129. Thornalley PJ, Bellavite P: Modification of the glyoxalase system during the functional
94. Beck WS: A kinetic analysis of the glycolytic rate and certain glycolytic enzymes in activation of human neutrophils. Biochim Biophys Acta 931:120, 1987.
normal and leucemic leucocytes. J Biol Chem 216:333, 1955. 130. Silber R, Gabrio BW, Huennekens FM: Studies on normal and leukemic leukocytes. III.
95. Borregaard N, Herlin T: Energy metabolism of human neutrophils during phagocyto- Pyridine nucleotides. J Clin Invest 41:230, 1962.
sis. J Clin Invest 70:550, 1982. 131. Willoughby HW, Waisman HA: Nucleic acid precursors and nucleotides in normal and
96. Lane TA, Beutler E, West C, Lamkin G: Glycolytic enzymes of stored granulocytes. leukemic blood. I. comparison of formic acid chromatograms. Cancer Res 17:942, 1957.
Transfusion 24:153, 1984. 132. Silber R, Unger KW, Ellman L: RNA metabolism in normal and leukaemic leucocytes:
97. Fauth U, Schlechtriemen T, Heinrichs W, et al: The measurement of enzyme activities in Further studies on RNA synthesis. Br J Haematol 14:261, 1968.
the resting human polymorphonuclear leukocyte—Critical estimate of a method. 133. Tryfiates GP, Laszlo J: Human leukemic polyribosomes. Proc Soc Exp Biol Med
Eur J Clin Chem Clin Biochem 31:5, 1993. 124:1125, 1967.
98. McKinney GR, Martin SP, Rundles RW, Green R: Respiratory and glycolytic activities of 134. Garcia AM, Iorio R: Studies on DNA in leukocytes and related cells of mammals. V. The
human leukocytes in vitro. J Appl Physiol 5:335, 1953. fast green-histone and the Feulgen-DNA content of rat leukocytes. Acta Cytol 12:46,
99. Stjernholm RL, Burns CP, Hohnadel JH: Carbohydrate metabolism by leukocytes. 1968.
Enzyme 13:7, 1972. 135. Smits G, Florijn E: The aneurinpyrophosphate content of red and white blood corpus-
100. Sbarra AJ, Karnovsky ML: The biochemical basis of phagocytosis. I. Metabolic changes cles in the rat and in man, in various states of aneurin provision and in disease. Biochim
during the ingestion of particles by polymorphonuclear leukocytes. J Biol Chem Biophys Acta 3:44, 1949.
234:1355, 1959. 136. Boxer GE, Pruss MP, Goodhart RS: Pyridoxal-5-phosphoric acid in whole blood and
101. Beck WS: Occurrence and control of the phosphogluconate oxidation pathway in nor- isolated leukocytes of man and animals. J Nutr 63:623, 1957.
mal and leukemic leukocytes. J Biol Chem 232:271, 1958. 137. Barkhan P, Howard AN: Distribution of ascorbic acid in normal and leukaemic human
102. Stjernholm RL, Manak RC: Carbohydrate metabolism in leukocytes. XIV. Regulation of blood. Biochem J 70:163, 1958.
pentose cycle activity and glycogen metabolism during phagocytosis. J Reticuloendothel 138. Hoffbrand AV, Newcombe BF: Leucocyte folate in vitamin B12 and folate deficiency
Soc 8:550, 1970. and in leukaemia. Br J Haematol 13:954, 1967.

Kaushansky_chapter 60_p0923-0938.indd 937 9/18/15 10:35 PM